Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
9/28/2023
CDE Solicits Comments on the Technical Guidelines for Clinical Efficac...
9/28/2023
CDE Issues on the Technical Guidelines for Clinical Trials of Dry Eye ...
9/28/2023
CDE Issues on the Technical Guidelines for Clinical Trials of Multiple...
9/28/2023
CDE Issues on the Technical Guidelines for Clinical Trials of Lupus Ne...
9/28/2023
CDE Issues on the Technical Guidelines for Clinical Trials of Drugs fo...
9/28/2023
Overview of Recent Anti-Corruption Enforcement Actions in the Pharmace...
9/27/2023
CDE Issues the Technical Guidelines for Non-clinical Research of Antib...
9/26/2023
China's Shifting Cost Dynamic to Help It Develop Own Biologics Niche: ...
9/26/2023
China Becomes Country with Highest and Increasingly Younger Alzheimer ...
9/26/2023
CDE Solicits Comments on the Technical Guidelines for the Assessment o...
9/26/2023
SAMR Imposed Fines and Confiscations Totaling Over CNY 300 Million in...
9/26/2023
Control Dispute with Hengrui Led to Dissolution Drama of Reistone Biop...
9/26/2023
Chinese Patents of Four MNC Originator Drugs Face Imminent Invalidatio...
9/26/2023
WuXi Debuts First Vaccine CDMO Site in China
9/26/2023
Patent Linkage In China: What The First Decisions Reveal About The Dir...
9/26/2023
AstraZeneca Looks To China For Growth - But CEO Says Spinoff Not Happe...
9/25/2023
CDE Solicits Comments on the Acceptance and Review Guide to GQCE Studi...
9/25/2023
CDE's Annual Review of Chinese Drug Evaluation and Registration in 202...
9/25/2023
AbbVie Terminates Deal with I-Mab to Exit Race for CD47 Space
9/25/2023
CDE Solicits Comments on the Technical Guidelines for Clinical Trial o...
9/24/2023
Chime Biologics Enter Global Strategic Deal with Panolos for Multi-spe...
9/24/2023
PackGene and Kudo Partner to Offer Customized mRNA Manufacturing Servi...
9/24/2023
Six Central Government Agencies Issue A New Batch of Rare Disease Cata...
9/24/2023
Strategies for Asian Business Navigating a New Era (McKinsey)
9/24/2023
Improving Access to Medicines and Beyond: the National Volume-based Pr...
9/21/2023
Meitheal Licenses U.S. Rights of Insulin Biosimilars from Tonghua Dong...
9/21/2023
Drug R&D and Product Registration News Digest 09/2023 (3)
9/21/2023
Recent Executive Moves
9/20/2023
NHSA Clears Two Additional Drugs from Form Evaluation for 2023 NRDL In...
9/20/2023
Everest Medicines Enters into Collaboration and License Agreement with...
Page:
32
/
718
Total number of articles:
21536
:
[First]
[<<]
[30]
[31]
[32]
[33]
[34]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit